Title
Alteration of substrate specificity of leucine dehydrogenase by site-directed
mutagenesis
Author(s)
片岡, 邦重; Kataoka, Kunishige; Tanizawa, Katsuyuki
Citation
Journal of molecular catalysis b enzymatic, 23(2-6): 299-309
Issue Date
2003-09
Type
Journal Article
Text version
author
URL
http://hdl.handle.net/2297/1731
Right
*KURAに登録されているコンテンツの著作権は,執筆者,出版社(学協会)などが有します。
*KURAに登録されているコンテンツの利用については,著作権法に規定されている私的使用や引用などの範囲内で行ってください。
*著作権法に規定されている私的使用や引用などの範囲を超える利用を行う場合には,著作権者の許諾を得てください。ただし,著作権者
から著作権等管理事業者(学術著作権協会,日本著作出版権管理システムなど)に権利委託されているコンテンツの利用手続については
,各著作権等管理事業者に確認してください。
http://dspace.lib.kanazawa-u.ac.jp/dspace/
Journal of Molecular Catalysis B: Enzymatic
(Regular paper)
Title:
Alteration of Substrate Specificity of Leucine Dehydrogenase by
Site-directed Mutagenesis1
Authors:
Kunishige Kataokaa,* and Katsuyuki Tanizawab
Affiliations:
a
Department of Chemistry, Faculty of Science, Kanazawa University, Kakuma, Kanazawa,
Ishikawa 920-1192, Japan
b
Department of Structural Molecular Biology, Institute of Scientific and Industrial Research,
Osaka University, Ibaraki, Osaka 567-0047, Japan
*Correspondence auther: (kataoka@cacheibm.s.kanazawa-u.ac.jp).
1
Dedicated to Professor Dr. Kenji Soda in honor of his 70th birthday.
1
Abstract
The residues L40, A113, V291, and V294, in leucine dehydrogenase (LeuDH),
predicted to be involved in recognition of the substrate side chain, have been mutated on the
basis of the molecular modeling to mimic the substrate specificities of phenylalanine (PheDH),
glutamate (GluDH), and lysine dehydrogenases (LysDH). The A113G and A113G/V291L
mutants, imitating the PheDH active site, displayed activities toward L-phenylalanine and
phenylpyruvate with 1.6 and 7.8% of kcat values of the wild-type enzyme for the preferred
substrates, L-leucine and its keto-analog, respectively. Indeed, the residue A113,
corresponding to G114 in PheDH, affects the volume of the side-chain binding pocket and has
a critical role in discrimination of the bulkiness of the side chain. Another two sets of mutants,
substituting L40 and V294 of LeuDH with the corresponding residues predicted in GluDH
and LysDH, were also constructed and characterized. Emergence of GluDH and LysDH
activities in L40K/V294S and L40D/V294S mutants, respectively, indicates that the two
corresponding residues in the active site of amino acid dehydrogenases are important for
discrimination of the hydrophobicity/polarity of the aliphatic substrate side chain. All these
results demonstrate that the substrate specificities of the amino acid dehydrogenases can be
altered by protein engineering. The engineered dehydrogenases are expected to be used for
production and detection of natural and non-natural amino acids.
Key words:
leucine dehydrogenase, substrate specificity, protein engineering, enzymatic synthesis
2
1. Introduction
Leucine dehydrogenase (LeuDH) [EC 1.4.1.9] is an NAD+- dependent
oxidoreductase that catalyzes the reversible deamination of L-leucine and some other
branched-chain L-amino acids to their keto analogs (Scheme 1). The enzyme occurs
ubiquitously in Bacillus species [1] and functions catabolically in the bacterial metabolism of
branched-chain L-amino acids [2]. It has been suggested that the enzyme plays an important
role in spore germination in cooperation with alanine dehydrogenase [3, 4]. The amino acid
dehydrogenase has considerable commercial potential for the production of novel nonproteinous amino acids in pharmaceutical industries [5, 6] and for the diagnosis of genetic
diseases of amino acid metabolisms including phenylketonuria [7], maple syrup urine disease
[8, 9], and homocystinuria [10].
H2 N
+
+
O
+ NAD + H2O!
COOH
+
+ NH
4 + NADH + H
COOH
Scheme 1
The thermostable LeuDH cloned from Bacillus stearothermophilus [11] shares
considerable sequence similarities in the catalytic and coenzyme-binding domains with the
enzymes acting on other amino acids, such as glutamate (GluDH) [12, 13], phenylalanine
(PheDH) [14, 15], and valine (ValDH) [16, 17] dehydrogenases. Although the overall
similarities among these enzymes are not high, sequence similarities between these
dehydrogenases clearly indicate the existence of an enzyme superfamily related by divergent
evolution [18]. However, the substrate specificities of this superfamily are different; GluDH
3
recognizes and binds glutamate in preference to all other amino acids [19], LeuDH and
ValDH catalyze the oxidation of only branched-chain, aliphatic amino acids [1, 20, 21], and
PheDH has a marked preference for aromatic amino acids as its substrate, although it also
accepts smaller hydrophobic amino acids with reduced efficiency [22, 23].
Results of structural studies in the last decade have revealed that these enzymes share
a very similar subunit structure, with each subunit composed of two domains separated by a
cleft harboring the active site [24-26]. To study the structure and function of the domains of
amino acid dehydrogenases before their crystal structures were available, we constructed and
characterized the chimeric enzyme consisting of an N-terminal domain of thermostable
PheDH from Thermoactinomyces intermedius and a C-terminal domain of LeuDH from B.
stearothermophilus [27]. Furthermore, we constructed and expressed genes of fragmentary
forms of B. stearothermophilus LeuDH to investigate the function of the enzyme domains
[28]. The results of our domain manipulation have suggested that the substrate specificity is
determined by structural interactions of the two domains, as corroborated from the presently
known crystal structures.
On the basis of the molecular structures of GluDH [24], LeuDH [25], and PheDH
[26], substrate specificity of amino acid dehydrogenases is explained by the types of residues
comprising the substrate side-chain binding pocket. In GluDH of Clostridium symbiosum, the
principal interactions that determine the specificity are between the γ-carboxyl group of the
substrate glutamate and the amino group of K89 and the hydroxyl group of S380, with G90,
A163, and V377 interacting with the hydrophobic component of the glutamate side chain [29].
In the Bacillus sphaericus LeuDH structure, the latter three residues are conserved (G41,
A113, and V291, respectively), whereas K89 and S380 in GluDH are replaced by L40 and
V294 in LeuDH (residue numbers refer to B. sphaericus LeuDH), making up a more
4
hydrophobic substrate side-chain binding pocket [25]. X-ray crystallographic and homologybased molecular modeling studies of PheDH revealed that this enzyme has a hydrophobic and
large side-chain binding pocket enough to bind the phenylalanine benzene ring by replacing
glycine for A113 of LeuDH [18, 30].
Several attempts have been made to alter the substrate specificities of the amino acid
dehydrogenase superfamily by molecular modeling. Wang et al. engineered a K89L/S380V
double mutant of GluDH, expecting that it would show substrate specificity of LeuDH with a
hydrophobic pocket [30], but the mutant had no activity because of steric clash of the pocket
[31]. The substrate specificity of B. sphaericus PheDH was successfully shifted toward that of
LeuDH by replacing G124 and L307 (corresponding to A163 and V377 in GluDH,
respectively) to alanine and valine, respectively [32]. More recently, Seah et al. succeeded in
modulating the specificity of B. sphaericus PheDH [33].
In the present study, aiming at altering the substrate specificity of B.
stearothermophilus LeuDH by homology-based modeling, we chose L40, A113, V291, and
V294 for a target of mutagenesis to mimic the substrate-binding pocket of PheDH, GluDH,
and LysDH. The detailed kinetic analysis of the mutant enzymes suggests that these residues
are important in the substrate side-chain recognition of the enzyme superfamily. The
alteration of substrate specificity by protein engineering presented here is not only of
scientific interest – understanding the structural basis for the difference in substrate
discrimination of the amino acid dehydrogenases – but also of applied one, possibly providing
an amino acid dehydrogenase with novel properties for production and detection of natural
and non-natural amino acids.
5
2. Experimental
2.1. Materials
A site-directed mutagenesis kit (Mutan-K), Taq DNA polymerase, T4 DNA ligation
kit, and DNA blunting kit were purchased from Takara Biochemicals (Japan). All reagents for
DNA synthesis and DNA sequencing were purchased from Applied Biosystems (U.S.A.). The
plasmid pICD2 carrying the leucine dehydrogenase gene of B. stearothermophilus and the
plasmid pKPDH2 containing the phenylalanine dehydrogenase gene of T. intermedius were
described previously [11, 14].
2.2. Mutagenesis
Substitutions of aspartate or lysine for L40, glycine for A113, leucine for V291, and
serine for V294 of LeuDH were performed by the method of Kunkel et al. [34] using a
commercial kit (Mutan-K), as described previously [35]. The following five oligonucleotide
primers were synthesized with an Applied Biosystems DNA synthesizer model 381 to contain
appropriate mismatched bases (indicated by asterisks) in the complementary codons for each
residue (underlined):
***
L40D: 5’-ATACGCGTCCCGCCTTTCGCCGGGCCGAG-3’
**
L40K: 5’-ATACGCGTCCCGCCGTCCGCCGGGCCGAG-3’
*
A113G: 5’-GACGTCTTCCCCCGTGATGTAG-3’
*
V291L: 5’-ACGTTGATGAGGCCGCCGGC-3’
**
V294S: 5’-TTCGTCCGCGGAGGTTGATGACG-3’
6
After confirming the nucleotide sequence of the mutant gene, appropriate restriction
fragments were replaced for the corresponding wild-type gene fragments in the LeuDH
expression plasmid pICD212.
Substitution of alanine for G114 of PheDH was performed by the two-step PCR
method as described previously [36] with two mutation primers shown below and pKPDH2 as
a template (1st PCR):
*
G114A-sense: 5’-AACGGCCGTTTCTATACCGCAACCGACATGGG-3’
*
G114A-antisense: 5’-CCATGTCGGTTGCGGTATAGAAAC-3’
After the second PCR using universal primers, the amplified fragment was
sequenced and digested with SacII and SplI. The digested fragment was replaced for the
corresponding wild-type gene fragments in pKPDH2.
2.3. Purification of the mutant enzyme
The wild-type and mutant enzymes of LeuDH were purified to homogeneity from the
crude extract of recombinant Escherichia coli cells grown at 37 °C for 12 h in Luria broth
supplemented with 50 µg/ml ampicillin and 0.5 mM IPTG, as described previously [11]. The
wild-type and G114A mutant of PheDH were also purified to homogeneity from the crude
extract of recombinant E. coli cells, as described previously [14].
2.4. Steady-state kinetic analysis
The oxidative deamination of L-amino acids and the reductive amination of α-keto
acids were measured by monitoring spectrophotometrically the appearance and disappearance,
7
respectively, of NADH under the conditions described previously [11]. The steady-state
kinetic parameters were determined by varying systematically the concentrations of both
substrate and coenzyme, except for ammonia, which was held at a constant, saturating
concentration (1.0 M). Protein concentrations of the wild-type and mutant LeuDH and the
wild-type and G114A PheDH were estimated using absorbencies (A0.1%) of 0.851 and 0.634 at
280 nm, respectively.
2.5. CD measurements
Circular dichroism (CD) spectra were measured at 25 °C in 10 mM potassium
phosphate buffer (pH 7.2) with a Jasco spectropolarimeter model J-600. In the calculation of
the mean residue ellipticity (s), the mean residue weight was taken to be 111 for the enzyme
protein. The CD spectra were obtained at a protein concentration of 0.2 mg/ml in a 2.0-cm
light path length cuvette for the measurements in the wavelength region above 250 nm and at
a protein concentration of 0.1 mg/ml in a 0.1-cm light path length cuvette for measurements
below 250 nm.
8
3. Results and Discussion
3.1. Molecular modeling and construction of mutant enzymes
Multiple sequence alignment of LeuDH, PheDH, and GluDH using structural
information of B. sphaericus LeuDH and C. symbiosum GluDH pointed out important
residues that are assumed to be the determinant of substrate side-chain binding (Fig. 1). This
homology-based modeling suggests that the difference in substrate specificity between
PheDH and LeuDH arises only from unacceptable steric interaction of the methyl group of
A113 of LeuDH with the substrate phenylalanine benzene ring, which are relieved in PheDH
by critical replacement of this residue by Gly114 [18]. To examine the validity of the models,
two mutant enzymes of LeuDH, in which Ala113 is replaced by glycine (A113G), and A113
and V291 are both replaced by glycine and leucine, respectively (A113G/V291L), have been
constructed. With the expectation of the opposite effect, we also prepared the mutant PheDH,
in which G114 was changed to alanine (G114A-PheDH) by PCR mutagenesis.
Furthermore, to alter the specificities of LeuDH toward GluDH or LysDH, L40,
corresponding to K89 in GluDH, whose ε-amino group interacts with the γ-carboxyl group of
the substrate L-glutamate by hydrogen bonding, has been mutated to lysine (L40K) or
aspartate (L40D). V294 of LeuDH, which is equivalent to S379 in GluDH that interacts with
the substrate glutamate by hydrogen bonding, has been replaced as well by serine for making
double mutants (L40K/V294S, L40D/V294S). In these variants, the hydrophilicity of the
substrate side-chain binding pocket increases, and the interaction of the substrate with the
polar side chain is expected.
All seven mutant enzymes were expressed and purified from the crude extract of
recombinant E. coli cells as the wild-type enzymes. After the purification, all mutant enzymes
9
exhibited a single prominent band on the SDS-PAGE gel with molecular sizes equivalent to
the wild-type LeuDH or PheDH (data not shown).
3.2. CD spectra of mutants
CD spectra of the wild-type and six mutant enzymes of LeuDH were measured to see
whether the global conformations were changed by the mutation. All the mutant enzymes
except A113G/V291L showed CD spectra practically identical with that of the wild-type
enzyme in the 200-250 nm region (Fig. 2), indicating that the wild-type and these mutant
enzymes contain very similar secondary structures. The decreased CD band of A113G/V291L
in this region indicates the decreased secondary structure content and some slight
conformational changes in the overall structure of this mutant.
On the other hand, the spectra of mutant enzymes in the 260-290 nm region, which
reflects the environment of aromatic residues, were significantly different from that of the
wild-type enzyme (Fig. 2A). The CD band of the wild-type LeuDH in this region is mainly
due to the sole tryptophan (W46), which is predicted to be located in the vicinity of the active
site [37]. The decreases in the near-UV CD bands of A113G and A113G/V291L indicate that
the environment around W46 of these mutants became more hydrophobic than that of the
wild-type enzyme, as in the case of mutations of the conserved glycine residues adjacent to
the catalytic K80 [37]. On the contrary, the spectrum of the L40D/V294S mutant in this
region, which is more negative than that of the wild-type, is indicative of a more hydrophilic
environment around W46 than in the wild-type enzyme.
CD spectrum of the G114A mutant of PheDH appeared essentially identical to that of
the wild-type enzyme (data not shown). Thus, the G114A mutant appears to have an identical
conformation to that of the wild-type PheDH.
10
3.3. Catalytic properties of A113G and A113G/V291L mutants of LeuDH and G114A
mutant of PheDH
Both single and double mutants of LeuDH prepared to mimic PheDH showed a
marked decrease in activities towards the aliphatic substrates compared to the wild-type
enzyme. The kcat values of the single mutant A113G and the double mutant A113G/V291L
decreased by about 20 and 60 folds for L-leucine, and by about 3 and 10 folds for α-keto-isocaproate, respectively (Table 2). The substrate specificities of A113G and A113G/V291L
were examined in the oxidative deamination with various amino acids and in the reductive
amination with various α-keto acids as substrate at 10 mM. The results are compared with
those of LeuDH and PheDH in Table 1. Both of the mutant enzymes have broader substrate
specificities than the wild-type LeuDH. The mutants act on, in addition to the preferred
substrate of LeuDH (short branched-chain amino acids including L-leucine, L-isoleucine, Lvaline, and their keto-analogs), poor substrates of LeuDH such as L-norleucine, L-norvaline,
L-methionine, L-ethionine, and α-keto-γ-methylthiobutyrate (long-chain aliphatic substrates).
Furthermore, these two mutants also utilize L-phenylalanine and phenylpyruvate with over
10% relative activity for the preferred substrate L-leucine and its keto-analog, while the wildtype enzyme does not respond at all to the substrates with aromatic side chains. This could be
attributed to the fact that the methyl side chain of A113 in LeuDH, which sterically interferes
with binding of the substrate aromatic ring, was removed by substitution to glycine.
Table 2 summarizes the kcat and Km values of the mutant and wild-type enzymes of
LeuDH and PheDH. Although the kcat value for L-leucine and its keto analog of the LeuDH
single mutant decreased considerably, the values for other aliphatic substrates did not change
so much. In addition, the Km values of A113G for aliphatic substrates are similar to the
11
corresponding values of the wild-type LeuDH. This result suggests that there is no significant
conformational change in the active site of the mutant upon replacement of A113 with glycine.
As expected from the molecular modeling, the single mutant showed PheDH activities, even
though they were merely 4% and 11%, respectively, of those of the wild-type PheDH in the
oxidative deamination of L-phenylalanine and reductive amination of phenylpyruvate. The Km
values of the A113G mutant for L-phenylalanine and its keto analog were also over 100 times
larger than the values of the wild-type PheDH. The low affinities of A113G for both Lphenylalanine and phenylpyruvate lead to a conclusion that the side-chain methyl group of
A113 in LeuDH is critical for discrimination between substrates with or without an aromatic
side chain but its absence does not contribute for increasing the affinity for aromatic
substrates.
In contrast with the single mutant, the kcat values of the A113G/V291L double
mutant of LeuDH greatly decreased with all the aliphatic substrates examined. Furthermore,
the Km values for all amino acid and α-keto acid substrates increased over 10 folds, although
there was not such a large change in the Km values for the coenzymes (NAD+ and NADH).
These results are consistent with the significantly altered CD properties of the double mutant
in the UV region, as described above. It is plausible that the double mutation has caused some
perturbation of local conformations in the substrate side-chain binding region.
The G114A mutant of PheDH showed broader substrate specificity than the wildtype enzyme, and the relative activity for the aliphatic substrates (L-isoleucine, L-norvaline,
L-methionine, α-keto-β-methylvalerate, and α-ketobutyrate) increased markedly (Table 1).
Despite the fact that the A113G mutant of LeuDH is considerably active with phenylalanine
and phenylpyruvate likely due to the removal of the side-chain methyl group, the G114A
mutant of PheDH still retains a low activity toward aromatic substrates (4.2% of kcat of the
12
wild-type PheDH for L-phenylalanine, Table 2). The broad substrate specificity of this mutant
is consistent with the specificities of the corresponding G124A and G124A/L307V mutants of
B. sphaericus PheDH, which also retained about 5% of activities for substrates with an
aromatic side chain [32]. Comparing the Km values of the G114A mutant with those of the
wild-type PheDH, we note that the values for aliphatic substrates are unchanged, although
those for both L-phenylalanine and phenylpyruvate increased by 160 times. Therefore, we
conclude that the affinity for aromatic substrates decreases specifically by introducing a
mutation in this position. The greatly decreased activity and the affinity towards aromatic
substrates with G114A indicate that G114 in PheDH is indeed critical for recognition of
aromatic substrates.
3.4. Catalytic properties of L40K and L40K/V294S mutants of LeuDH
The substrate specificities of the mutants that were designed to mimic the active site
of GluDH were also studied in both the oxidative deamination and reductive amination
reactions (Table 3). The specificity of the single mutant L40K, in which L40 of LeuDH has
been replaced by lysine, corresponding to K89 in GluDH that plays a role in anchoring the γcarboxyl group of the substrate L-glutamate, did not change greatly from that of the wild-type
LeuDH. It could react neither with L-glutamate nor with α-ketoglutarate as substrates. In
contrast, the double mutant L40K/V294S with an additional mutation of V294 to serine
(equivalent to S379 in GluDH, interacting with the substrate side chain) has a weak GluDH
activity, as expected from the molecular modeling. The double mutant of LeuDH acts on
polar amino acids such as L-asparagine, L-aspartate, L-glutamine, and L-glutamate, in
addition to the preferred substrates of the wild-type enzyme.
13
The kinetic parameters of the single and double mutants of LeuDH in both
deamination and amination reactions are presented in Table 4. The single mutant showed
reduced kcat values as compared to those of the double mutant having similar values with the
wild-type enzyme. The Km values of the single mutant for L-isoleucine, L-norleucine, α-ketoiso-caproate, and α-keto-β-methylvalerate increased by more than 10 folds as compared to the
wild-type. The kinetic parameters of L40K are similar to those obtained with the K89L
mutant of GluDH, prepared in a manner opposite to the present studies [31]. Both of the
single mutants (L40K of LeuDH and K89L of GluDH) displayed large reductions in the
original catalytic activities and failed to reverse the substrate specificities. In the L40K mutant,
the positively charged lysine side chain has been introduced, but the hydrophobic valine
remains in position 294. The K89L mutant of GluDH has oppositely the L89/S379 pair.
Presumably, these incompatible pairings of side chains cannot be stabilized by binding of the
normal or alternative substrates.
In marked contrast to the single mutant, the double mutant of LeuDH (L40K/V294S)
showed kcat values even similar to those of the wild-type enzyme (except for L-leucine).
However, the double mutant had high Km values for the preferred substrates of LeuDH, like
the single mutant. Although the single and double mutants had slight activities toward Lglutamate and α-ketoglutarate, the catalytic rates with the two substrates were unsaturable
with their concentrations (data not shown); thus the Km values for L-glutamate and αketoglutarate could not be obtained, and the kcat values, determined with the substrate at 50
mM, shown in Table 4 are a lower limit. The high Km values of the double mutant for
aliphatic substrates are indicative of the increased hydrophilicity of the pocket that is
advantageous for binding an acidic substrate, but further fine tuning of the substrate-binding
pocket is certainly required to realize the high affinity for L-glutamate.
14
3.5. Catalytic Properties of L40D and L40D/V294S mutants of LeuDH
We constructed another set of mutant enzymes of LeuDH in order to confer the
activity for the substrates with a positively charged side chain (L-lysine and L-arginine). As
shown in Table 3, the substrate specificities of the single (L40D) and double (L40D/V294S)
mutants for aliphatic amino acids were virtually unaffected as compared with the wild-type
enzyme. These mutants, however, displayed entirely new activities for L-lysine and Larginine, even in the single mutant (L40D), unlike in the case of the L40K mutant described
above.
However, the substitution of L40 with aspartate caused marked reductions of kcat
values for aliphatic substrates (lower by ~100 folds) compared with those of the wild-type
LeuDH (Table 4). Moreover, the Km values for these preferred substrates increased much; for
example, the values for L-leucine, L-isoleucine, and L-norleucine were too high to determine.
The large reduction of activities of the mutants for aliphatic substrates seems to be mainly due
to the increased Km values. The kcat values of the single and double mutants for deamination
of L-lysine were 0.029 and 0.45 s–1, which were only 0.06 and 0.9%, respectively, of that for
L-leucine of the wild-type LeuDH. Nevertheless, the Km values of the mutants for L-lysine
were only one order of magnitude higher than those for aliphatic substrates of the wild-type
enzyme. These kinetic properties, together with the CD spectrum of the L40D/V294S mutant,
suggest that the hydrophilicity of the substrate side-chain binding pocket, enhanced by the
substitutions of L40 by aspartate and V294 by serine, is important in permitting the binding of
a substrate with a positively charged side chain such as L-lysine.
15
4. Conclusions
Enzymes belonging to the amino acid dehydrogenase superfamily have already been
used to produce various amino acids in commercially feasible quantities. Understanding the
molecular mechanisms for the distinct substrate specificities displayed by these enzymes
would enable us to engineer the substrate specificities by site-directed mutagenesis and
further facilitate their applications to the enzymatic production or detection of novel amino
acids.
In the studies herein reported, we constructed three types of mutant enzymes of
LeuDH to mimic the substrate specificities of PheDH, GluDH, and LysDH by protein
engineering. The kinetic parameters obtained with these mutants clearly showed that A113,
V294, L40, and V294 in LeuDH are the key residues involved in recognition of the substrate
side chain. A113 in LeuDH and the corresponding G114 in PheDH control the volume of the
side-chain binding pocket and play a critical role in discrimination of the bulkiness of the side
chain. Emergence of GluDH and LysDH activities in the L40K/V294S and L40D/V294S
mutants, respectively, indicates that the two residues in the active sites of the amino acid
dehydrogenases are important for discrimination of the hydrophobicity/polarity/charge of
aliphatic substrate side chains.
Acknowledgements
This work was supported by a Grant-in-Aid for Encouragement of Young Scientists
(to K.K., No. 07780537) from the Ministry of Education, Science, Sports and Culture of Japan.
16
References
[1] T. Ohshima, H. Misono and K. Soda, J. Biol. Chem., 253 (1978) 5719
[2] M.W. Zink and B.D. Sanwal, Arch. Biochem. Biophys., 99 (1962) 72
[3] J. Hermier, J.M. Lebeault and C. Zevako, Bull. Soc. Chim. Biol., 52 (1970) 1089
[4] J. Hermier, M. Rosseau and C. Zevako, Ann. Inst. Pasteur Paris, 118 (1970) 611
[5] R.L. Hanson, J. Singh, T.P. Kissick, R.N. Patel, L.J. Szarka and R.H. Mueller, Bioorg.
Chem., 18 (1990) 371
[6] A.S. Bommarius, M. Schwarn and K. Drauz, J. Mol. Catal. B: Enzymatic, 5 (1998) 1
[7] K.C. Dooley, Clin. Biochem., 25 (1992) 271
[8] G. Livesey and P. Lund, Methods Enzymol., 166 (1988) 3
[9] A. Yamaguchi, Y. Mizushima, M. Fukushi, Y. Shimizu, Y. Kikuchi and N. Takasugi,
Screening, 1 (1992) 49
[10] S.H. Mudd, H.L. Levy and F. Skovby, in C.R. Sciver, A.L. Beudet, W.S.Sly and D. Valle
(Ed.), The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1989, p. 693
[11] S. Nagata, K. Tanizawa, N. Esaki, Y. Sakamoto, T. Ohshima, H. Tanaka and K. Soda,
Biochemistry, 27 (1989) 9056
[12] J.K. Teller, R.J. Smith, M.J. McPherson, P.C. Engel and J.R. Guest, Eur. J. Biochem.,
206 (1992) 151
[13] M.J. McPherson and J.C. Wootton, Nucleic Acid Res., 11 (1983) 5257
[14] H. Takada, T. Yoshimura, T. Ohshima, N. Esaki and K. Soda, J. Biochem., 109 (1991)
371
[15] N. Okazaki, Y. Hibino, Y. Asano, M. Ohmori, N. Numao and K. Kondo, Gene, 63
(1988) 337
[16] A. Leiser, A. Birch and J.A. Robinson, Gene (Amst.), 177 (1996) 217
17
[17] L. Tang and C.R. Hutchinson, J. Bacteriol., 175 (1993) 4176
[18] K.L. Britton, P.J. Baker, P.C. Engel, D.W. Rice and T.J. Stillman, J. Mol. Biol., 234
(1993) 938
[19] S.E.H. Syed, P.C. Engel and D.M. Parker, Biochim. Biophys. Acta, 1115 (1991) 123
[20] T. Ohshima, N. Nishida, S. Bakthavatsalam, K. Kataoka, H. Takada, T. Yoshimura, N.
Esaki and K. Soda, Eur. J. Biochem., 222 (1994) 305
[21] N.D. Priestley and J.A. Robinson, Biochem. J., 261 (1989) 853
[22] Y. Asano, A. Nakazawa and K. Endo, J. Biol. Chem., 262 (1987) 10346
[23] T. Ohshima, H. Takada, T. Yoshimura, N. Esaki and K. Soda, J. Bacteriol., 173 (1991)
3943
[24] P.J. Baker, K.L. Britton, P.C. Engel, G.W. Farrants, K.S. Lilley, D.W. Rice and T.J.
Stillman, Proteins, 12 (1992) 75
[25] P.J. Baker, A.P. Turnbull, S.E. Sedelnikova, T.J. Stillman and D.W. Rice, Structure, 3
(1995) 693
[26] J.L. Vanhooke, J.B. Thoden, N.M.W. Brunhuber, J.S. Blanchard and H.M. Holden,
Biochemistry, 38 (1999) 2326
[27] K. Kataoka, H. Takada, K. Tanizawa, T. Yoshimura, N. Esaki, T. Ohshima and K. Soda,
J. Biochem., 116 (1994) 931
[28] T. Oikawa, K. Kataoka, Y. Jin, S. Suzuki and K. Soda, Biochem. Biophys. Res.
Commun., 280 (2001) 1177
[29] T.J. Stillman, P.J. Baker, K.L. Britton and D.W. Rice, J. Mol. Biol., 234 (1993) 1131
[30] P.J. Baker, M.L. Waugh, X.-G. Wang, T.J. Stillman, A.P. Turnbull, P.C. Engel and D.W.
Rice, Biochemistry, 36 (1997) 16109
18
[31] X.-G. Wang, K.L. Britton, P.J. Baker, S. Martin, D.W. Rice and P.C. Engel, Protein Eng.,
8 (1995) 147
[32] Y.K. Seah, K.L. Britton, P.J. Baker, D.W. Rice, Y. Asano and P.C. Engel, FEBS Lett.,
370 (1995) 93
[33] Y.K. Seah, K.L. Britton, D.W. Rice, Y. Asano and P.C. Engel, Biochemistry, 41 (2002)
11390
[34] T.A. Kunkel, J.D. Roberts and R.A. Zakour, Methods Enzymol., 154 (1987) 367
[35] K. Kataoka, K. Tanizawa, T. Fukui, H. Ueno, T. Yoshimura, N. Esaki and K. Soda, J.
Biochem., 116 (1994) 1370
[36] K. Kataoka, M. Nakai, K. Yamaguchi and S. Suzuki, Biochem. Biophys. Res. Commun.,
250 (1998) 409
[37] T. Sekimoto, T. Fukui and K. Tanizawa, J. Biochem., 116 (1994) 176
19
Figure legends
Fig. 1. Sequence alignment of amino acid dehydrogenases using structural information from
B. sphaericus LeuDH and C. symbiosum GluDH. Residues L40, A113, V291, and V294 of B.
stearothermophilus LeuDH and their corresponding residues are shown with white letters in
black background.
Fig. 2. CD spectra of the wild-type and mutant enzymes of LeuDH. The CD spectra were
recorded at 25 ºC in 10 mM potassium phosphate buffer (pH 7.2). (A) Spectra of the wildtype (solid line), A113G (broken line), and A113G/V291L (dotted line) mutant enzymes. (B)
Spectra of the wild-type (solid line), L40K (broken line), and L40K/V294S (dotted line)
mutant enzymes. (C) Spectra of the wild-type (solid line), L40D (broken line), and
L40D/V294S (dotted line) mutant enzymes. The unit of [θ] is mdeg•cm2•dmol–1.
20
Table 1. Substrate specificities of wild-type and mutant enzymes
a
Substrate (10 mM)
Wild type
Relative activity (%)
LeuDH
PheDH
A113G
AG/V291L
Wild type
G114A
Deamination
L-Leucine
L-Isoleucine
L-Valine
L-Norleucine
L-Norvaline
L-Methionine
L-Ethionine
L-Alanine
L-Phenylalanine
L-Tyrosine
L-Tryptophan
L-Histidine
L-Glutamate
100
54
39
14
56
0.7
0
0
0
0
0
0
0
100
550
62
530
110
81
35
0
15
0
0
0.4
0
100
150
13
110
23
19
12
0
11
0
0
0
0
3.9
0.4
1.3
6.3
2.1
2.2
4.0
0.4
100
40
1.2
0.2
0
42
90
39
66
72
72
11
3.5
100
5.4
0
1.3
0
Amination
α-Keto-iso-caproate
α-Keto-β-methylvalerate
α-Ketovalerate
α-Keto-γ-methylthiobutyrate
α-Ketobutyrate
Phenylpyruvate
p-Hydroxyphenylpyruvate
100
100
86
15
47
0
0
100
180
102
130
5.1
17
0
100
67
19
36
0.6
11
0
47
16
37
55
5.5
100
80
151
174
224
102
104
100
0
a
Specific activities of the wild-type and mutant enzymes of LeuDH and PheDH for various
substrates are shown as % activities relative to the values for L-leucine and L-phenylalanine,
respectively, taken as 100.
21
a
Table 2. Steady-state kinetic parameters of wild-type and mutant enzymes
LeuDH
A113G
A113G/V291L
PheDH
G114A
–1
kcat (s )
L-Leucine
L-Isoleucine
L-Norleucine
L-Norvaline
L-Phenylalanine
α-Keto-iso-caproate
α-Keto-β-methyl
valerate
α-Ketocaproate
Phenylpyruvate
Km (mM)
L-Leucine
L-Isoleucine
L-Norleucine
L-Norvaline
L-Phenylalanine
α-Keto-iso-caproate
α-Keto-β-methyl
valerate
α-Ketocaproate
Phenylpyruvate
NAD+ (µM)
NADH (µM)
a
50 ± 3.0
28 ± 0.77
1.3 ± 0.03
13 ± 0.15
0
2.8 ± 0.08
0.74 ± 0.010
0.20 ± 0.006
0.12 ± 0.002
23 ± 0.53
1.4 ± 0.037
0.24 ± 0.02
0.22 ± 0.006
18 ± 0.04
0.60 ± 0.018
1.9 ± 0.005
0.16 ± 0.004
7.7 ± 0.19
0.29 ± 0.008
0.59 ± 0.006
0.21 ± 0.004
0.80 ± 0.004
1.4 ± 0.049
23 ± 0.27
0.97 ± 0.012
280 ± 22
94 ± 1.9
29 ± 0.35
36 ± 0.49
37 ± 0.48
280 ± 4.1
235 ± 5.2
37 ± 0.52
26 ± 0.22
46 ± 0.24
110 ± 2.4
140 ± 2.8
24 ± 0.91
79 ± 1.1
61 ± 0.49
9.9 ± 1.2
200 ± 1.3
36 ± 0.46
0
22 ± 0.70
5.1 ± 0.50
1.4 ± 0.10
35 ± 2.5
0.12 ±0.006
0.082 ± 0.002
2.4 ± 0.15
7.8 ± 0.49
33 ± 1.8
0.081 ± 0.007
0.082 ± 0.003
4.4 ± 0.21
4.1 ± 0.026
24 ± 1.6
0.19 ± 0.002
0.17 ± 0.008
27 ± 1.8
70 ± 8.6
0.50 ± 0.016
0.18 ± 0.006
31 ± 1.2
66 ± 7.1
0.10 ± 0.003
4.4 ± 0.19
7.8 ± 0.29
─
0.88 ± 0.15
1.7 ± 0.11
30 ± 2.7
3.8 ± 0.16
9.4 ± 0.59
69 ± 5.1
4.7 ± 0.34
2.0 ± 0.10
28 ± 2.9
─
7.1 ± 1.1
9.9 ± 1.2
12 ± 0.45
2.5 ± 0.11
0.065 ± 0.003
16 ± 0.42
4.1 ± 0.16
5.2 ± 0.067
4.4 ± 0.11
11 ± 0.47
63 ± 7
76 ± 1
280 ± 13
170 ± 10
50 ± 20
35 ± 6
42 ± 2
17 ± 7
83 ± 1
27 ± 7
Steady-state kinetic parameters were determined by varying the concentration of the
substrate to be measured in the presence of fixed concentrations of the cofactor and cosubstrate (1.25 mM NAD+ in the oxidative deamination and 0.1 mM NADH and 1 M
ammonia in the reductive amination).
22
Table 3. Substrate specificities of wild-type and mutant enzymes of LeuDH
a
Substrate (10 mM)
Wild type
Relative activity (%)
L40K
L40K/V294S
L40D
L40D/V291S
Deamination
L-Leucine
L-Isoleucine
L-Valine
L-Norleucine
L-Norvaline
L-Methionine
L-Ethionine
L-Alanine
L-Phenylalanine
L-Histidine
L-Asparagine
L-Glutamine
L-Aspartate
L-Glutamate
L-Lysine
L-Arginine
100
54
39
14
56
0.7
0
0
0
0
0
0
0
0
0
0
100
273
81
28
29
2.6
0.5
0.04
0
0.02
0
0
0
0
0
0
100
187
26
17
24
3.6
0.2
0
0
0
0.1
0.4
0.04
0.1
0
0
100
212
64
35
37
3.0
0
0
0
0
0
0
0
0
9.2
1.8
100
358
45
27
33
4.2
0
0
0
0
0
0
0
0
38
1.1
Amination
α-Keto-iso-caproate
α-Keto-β-methylvalerate
α-Ketovalerate
α-Ketobutyrate
100
100
86
47
100
86
100
58
30
2.7
100
92
52
6.1
100
63
a
b
ND
b
ND
Specific activities of the wild-type and mutant enzymes of LeuDH for various substrates are
shown as % activities relative to the values for L-leucine, taken as 100.
b
b
ND
b
ND
Not determined.
23
a
Table 4. Steady-state kinetic parameters of wild-type and mutant enzymes of LeuDH
Wild type
L40K
L40K/V294S
L40D
L40D/V291S
–1
kcat (s )
L-Leucine
L-Isoleucine
L-Norleucine
L-Glutamate
L-Lysine
50 ± 3.0
28 ± 0.77
1.3 ± 0.03
0
0
α-Keto-iso-caproate 280 ± 22
α-Keto-β-methyl
280 ± 4.1
valerate
α-Ketoglutarate
0
Km (mM)
L-Leucine
L-Isoleucine
L-Norleucine
L-Glutamate
L-Lysine
α-Keto-iso-caproate
α-Keto-β-methyl
valerate
α-Ketoglutarate
a
5.1 ± 0.50
2.4 ± 0.15
4.4 ± 0.21
3.8 ± 0.038
1.8 ± 0.41
1.9 ± 0.04
0
0
9.8 ± 0.054
17 ± 0.46
1.7 ± 0.03
b
0.02
0
b
b
0.21
b
0.49
b
0.070
0
0.029 ± 0.001
0.80
b
2.8
b
0.22
0
0.45 ± 0.03
95 ± 1.7
270 ± 5.9
9.9 ± 0.051
47 ± 0.50
82 ± 1.6
280 ± 3.5
1.9 ± 0.024
30 ± 0.47
b
0
0
0.57
5.2 ± 3.7
64 ± 1.8
110 ± 3.0
─
─
26 ± 0.52
24 ± 1.5
27 ± 1.1
c
ND
─
─
─
0
c
c
ND
c
ND
c
ND
ND
c
ND
c
ND
─
─
64 ± 3.9
72 ± 5.0
0.88 ± 0.15
46 ± 3.2
42 ± 3.3
260 ± 22
120 ± 11
3.8 ± 0.16
49 ± 3.8
84 ± 6.7
47 ± 2.4
110 ± 14
─
c
ND
─
─
─
Steady-state kinetic parameters were determined by varying the concentration of the
substrate to be measured in the presence of fixed concentrations of the cofactor and cosubstrate (1.25 mM NAD+ in the oxidative deamination and 0.1 mM NADH and 1 M
ammonia in the reductive amination).
b
c
Determined for the substrate at 50 mM.
Not determined due to the catalytic rates,being unsaturable with the substrate concentrations.
24
!c
LeuDH B. sphaericus
LeuDH B. stearo.
LeuDH T. intermedius
PheDH T. intermedius
PheDH B. sphaericus
GluDH E. coli
GluDH C. symbiosum
GPALGGARMF
GPALGGTRMW
37
GPALGGMRMW
38
GPALGGCRMI
48
GPALGGTRMY
90
GPYKGGMRFH
86
GPYKGGLRFA
37
37
!e
"4
RYITAEDVGTTVSDM
RYITAEDVGTTVADM
109
RYITAEDVGTTVEDM
110
RFYTGTDMGTNPEDF
120
RFYTGTDMGTTMDDF
163
TDVPAGDIGVGGREV
160
IDVPAGDLGVGAREI
109
109
!c
!e
Fig.1
25
"8
"12
YVINAGGVINVADELYGY
YVINAGGVINVADELYGY
284
YVINAGGVINVADELLGY
287
YLVNAGGLIQVADELEGP
270
YLVNAGGLIQVADELEGP
371
KAANAGGVATSGLEMAQN
370
KAVNAGGVLVSGFEMSQN
284
284
"15a
"15b
1
A
0
0
-2
-1
-4
-2
-6
-3
B
0
0
-2
-1
-4
-2
-6
-3
C
0
0
-2
-1
-4
-2
-6
200
220
240
260
280
300
Wavelength (nm)
26
-3
320
[!]x10-2
[!]x10-4
2